Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-Breast12, KEYNOTE-522, CAPItello-290 & ICARUS-Breast01
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Paolo Tarantino
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Paolo Tarantino
641 views
September 24, 2024
Chapters
NATALEE Trial & Adjuvant Ribociclib Outcomes
00:00
DESTINY-Breast12: T-DXd in HER2-Positive Cancer
04:12
KEYNOTE-522: Pembrolizumab's Survival Impact
06:46
CAPitello-290: AKT Inhibition in TNBC
09:11
ICARUS-Breast01: HER3-DXd Efficacy & Safety
11:45
Login to view comments.
Click here to Login